Evaluation of the Mass Drug Administration Intervention for Lymphatic Filariasis Elimination in The Ikeduru Local Government Area

Nigeria has a serious public health threat from lymphatic filariasis (LF), which is why Mass Drug Administration (MDA) programs are being implemented as a preventive measure. With an emphasis on community viewpoints and influencing variables, this study examines the adoption and development of MDA in twelve communities within the Ikeduru Local Government Area. To determine the start and extent of MDA in Ikeduru communities, assess community acceptability and involvement in the MDA intervention, and pinpoint variables impacting MDA coverage and community attitudes. to suggest modifications for improved MDA efficiency and drug acceptability based on local expertise. Using a cross-sectional survey methodology, 384 respondents from twelve carefully chosen communities in Ikeduru LGA were the subject of the investigation. A standardized questionnaire that was approved by university lecturers was used to gather the data. For data analysis, descriptive and inferential statistics were used. Since 2014, MDA has been continuously applied throughout all of the Ikeduru communities, resulting in complete coverage. Ninety-nine percent of the community actively participates in MDA, demonstrating a high level of community acceptance and support. The success of MDA can be attributed to enabling characteristics such as house-to-house distribution, convenient access, knowledgeable distributors, and instructive services. Disabling issues include time limits, unfavorable distributors, drug shortages, and distance. Drug acceptance factors are in line with MDA trends, and incentives have been found to be a substantial enhancer. The research highlights the triumphant execution of MDA in Ikeduru, characterized by extensive community endorsement and efficient coverage. The program's success is attributed to identified enabling elements, whilst obstacles require focused actions. Recommendations from the community emphasize the need for improved drug quality, accessibility, professionalism, and incentives. These proposals provide insightful information for program enhancement.